P47197
Gene name |
Akt2 |
Protein name |
RAC-beta serine/threonine-protein kinase |
Names |
EC 2.7.11.1 , Protein kinase Akt-2 , Protein kinase B beta , PKB beta , RAC-PK-beta |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:25233 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
143-481 (Kinase domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
152-409 (Protein kinase domain) |
Relief mechanism |
Ligand binding, PTM |
Assay |
|
Accessory elements
292-315 (Activation loop from InterPro)
Target domain |
152-478 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Huang X et al. (2003) "Crystal structure of an inactive Akt2 kinase domain", Structure (London, England : 1993), 11, 21-30
- Truebestein L et al. (2021) "Structure of autoinhibited Akt1 reveals mechanism of PIP(3)-mediated activation", Proceedings of the National Academy of Sciences of the United States of America, 118,
- Lučić I et al. (2018) "Conformational sampling of membranes by Akt controls its activation and inactivation", Proceedings of the National Academy of Sciences of the United States of America, 115, E3940-E3949
- Ashwell MA et al. (2012) "Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors", Journal of medicinal chemistry, 55, 5291-310
Autoinhibited structure

Activated structure

1 structures for P47197
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P47197-F1 | Predicted | AlphaFoldDB |
No variants for P47197
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for P47197 |
No associated diseases with P47197
6 regional properties for P47197
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Tyrosine-specific protein phosphatase, PTPase domain | 243 - 517 | IPR000242 |
domain | Tyrosine-specific protein phosphatases domain | 430 - 506 | IPR000387 |
domain | SH2 domain | 2 - 100 | IPR000980-1 |
domain | SH2 domain | 108 - 213 | IPR000980-2 |
domain | Protein-tyrosine phosphatase, catalytic | 408 - 514 | IPR003595 |
active_site | Protein-tyrosine phosphatase, active site | 451 - 461 | IPR016130 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
10 GO annotations of cellular component
Name | Definition |
---|---|
cell cortex | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
early endosome | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. |
insulin-responsive compartment | A small membrane-bounded vesicle that releases its contents by exocytosis in response to insulin stimulation; the contents are enriched in GLUT4, IRAP and VAMP2. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
ruffle membrane | The portion of the plasma membrane surrounding a ruffle. |
sarcoplasmic reticulum | A fine reticular network of membrane-limited elements that pervades the sarcoplasm of a muscle cell; continuous over large portions of the cell and with the nuclear envelope; that part of the endoplasmic reticulum specialized for calcium release, uptake and storage. |
vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
7 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
metal ion binding | Binding to a metal ion. |
molecular function activator activity | A molecular function regulator that activates or increases the activity of its target via non-covalent binding that does not result in covalent modification to the target. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction |
protein kinase C binding | Binding to protein kinase C. |
protein serine kinase activity | Catalysis of the reactions |
protein serine/threonine kinase activity | Catalysis of the reactions |
38 GO annotations of biological process
Name | Definition |
---|---|
cellular response to high light intensity | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a high light intensity stimulus. |
cellular response to hormone stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
cellular response to insulin stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
cellular response to organic cyclic compound | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
glucose metabolic process | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
glycogen biosynthetic process | The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues. |
insulin receptor signaling pathway | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of long-chain fatty acid import across plasma membrane | Any process that decreases the rate, frequency or extent of plasma membrane long-chain fatty acid transport. Plasma membrane long-chain fatty acid transport is the directed movement of long-chain fatty acids across the plasma membrane. |
negative regulation of RNA splicing | Any process that stops, prevents, or reduces the frequency, rate or extent of RNA splicing. |
organic substance transport | The directed movement of organic substances into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore. An organic substance is a molecular entity that contains carbon. |
peripheral nervous system myelin maintenance | The process in which the structure and material content of mature peripheral nervous system myelin is kept in a functional state. |
phosphatidylinositol 3-kinase/protein kinase B signal transduction | A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of cell motility | Any process that activates or increases the frequency, rate or extent of cell motility. |
positive regulation of fatty acid beta-oxidation | Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of glucose import | Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
positive regulation of glucose metabolic process | Any process that increases the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. |
positive regulation of glycogen biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
positive regulation of nitric oxide biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
positive regulation of peptidyl-serine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
positive regulation of positive chemotaxis | Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of protein targeting to membrane | Any process that increases the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein. |
positive regulation of signal transduction | Any process that activates or increases the frequency, rate or extent of signal transduction. |
positive regulation of sodium ion transport | Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
protein localization to nucleus | A process in which a protein transports or maintains the localization of another protein to the nucleus. |
protein localization to plasma membrane | A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane. |
regulation of translation | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
response to insulin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
response to muscle activity | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus. |
response to nutrient levels | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
retinal rod cell apoptotic process | Any apoptotic process in a retinal rod cell, one of the two photoreceptor cell types of the vertebrate retina. |
23 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q01314 | AKT1 | RAC-alpha serine/threonine-protein kinase | Bos taurus (Bovine) | SS |
Q8INB9 | Akt | RAC serine/threonine-protein kinase | Drosophila melanogaster (Fruit fly) | SS |
Q9Y243 | AKT3 | RAC-gamma serine/threonine-protein kinase | Homo sapiens (Human) | SS |
P31749 | AKT1 | RAC-alpha serine/threonine-protein kinase | Homo sapiens (Human) | EV |
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | Homo sapiens (Human) | EV SS |
P31750 | Akt1 | RAC-alpha serine/threonine-protein kinase | Mus musculus (Mouse) | PR |
Q9WUA6 | Akt3 | RAC-gamma serine/threonine-protein kinase | Mus musculus (Mouse) | PR |
Q60823 | Akt2 | RAC-beta serine/threonine-protein kinase | Mus musculus (Mouse) | PR |
O55173 | Pdpk1 | 3-phosphoinositide-dependent protein kinase 1 | Rattus norvegicus (Rat) | SS |
P09217 | Prkcz | Protein kinase C zeta type | Rattus norvegicus (Rat) | SS |
F1M7Y5 | Prkci | Protein kinase C iota type | Rattus norvegicus (Rat) | SS |
Q63433 | Pkn1 | Serine/threonine-protein kinase N1 | Rattus norvegicus (Rat) | SS |
Q64617 | Prkch | Protein kinase C eta type | Rattus norvegicus (Rat) | PR |
P09215 | Prkcd | Protein kinase C delta type | Rattus norvegicus (Rat) | PR |
P63319 | Prkcg | Protein kinase C gamma type | Rattus norvegicus (Rat) | SS |
P47196 | Akt1 | RAC-alpha serine/threonine-protein kinase | Rattus norvegicus (Rat) | PR |
Q63484 | Akt3 | RAC-gamma serine/threonine-protein kinase | Rattus norvegicus (Rat) | PR |
O08874 | Pkn2 | Serine/threonine-protein kinase N2 | Rattus norvegicus (Rat) | SS |
P09216 | Prkce | Protein kinase C epsilon type | Rattus norvegicus (Rat) | PR |
P05696 | Prkca | Protein kinase C alpha type | Rattus norvegicus (Rat) | SS |
P68403 | Prkcb | Protein kinase C beta type | Rattus norvegicus (Rat) | SS |
Q9XTG7 | akt-2 | Serine/threonine-protein kinase akt-2 | Caenorhabditis elegans | SS |
Q17941 | akt-1 | Serine/threonine-protein kinase akt-1 | Caenorhabditis elegans | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MNEVSVIKEG | WLHKRGEYIK | TWRPRYFLLK | SDGSFIGYKE | RPEAPDQTLP | PLNNFSVAEC |
70 | 80 | 90 | 100 | 110 | 120 |
QLMKTERPRP | NTFVIRCLQW | TTVIERTFHV | DSPDEREEWI | RAIQMVANSL | KQRGPGEDAM |
130 | 140 | 150 | 160 | 170 | 180 |
DYKCGSPSDS | STSEMMEVAV | SKARAKVTMN | DFDYLKLLGK | GTFGKVILVR | EKATGRYYAM |
190 | 200 | 210 | 220 | 230 | 240 |
KILRKEVIIA | KDEVAHTVTE | SRVLQNTRHP | FLTALKYAFQ | THDRLCFVME | YANGGDLFFH |
250 | 260 | 270 | 280 | 290 | 300 |
LSRERVFTED | RARFYGAEIV | SALEYLHSTD | VVYRDIKLEN | LMLDKDGHIK | ITDFGLSKEG |
310 | 320 | 330 | 340 | 350 | 360 |
ISDGATMKTF | CGTPEYLAPE | VLEDNDYGRA | VDWWGLGVVM | YEMMCGRLPF | YNQDHERLFE |
370 | 380 | 390 | 400 | 410 | 420 |
LILMEEIRFP | RTLGPEAKSL | LAGLLKKDPK | QRLGGGPSDA | KEVMEHRFFL | SINWQDVVQK |
430 | 440 | 450 | 460 | 470 | 480 |
KLLPPFKPQV | TSEVDTRYFD | DEFTAQSITI | TPPDRYDSLG | SLELDQRTHF | PQFSYSASIR |
E |